Gully, Christopher P <br/><br/>
Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer.  [electronic resource] 

 -  Molecular cancer  Feb 2010 
 - 42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-9-42  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aneuploidy<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Aurora Kinase B<br/>Aurora Kinases<br/>Breast Neoplasms--drug therapy<br/>Cell Proliferation--drug effects<br/>Female<br/>G2 Phase--drug effects<br/>Humans<br/>Mice<br/>Mitosis--drug effects<br/>Neoplasm Metastasis<br/>Organophosphates--pharmacology<br/>Polyploidy<br/>Polyubiquitin--metabolism<br/>Proteasome Endopeptidase Complex--metabolism<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Processing, Post-Translational--drug effects<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>Tumor Stem Cell Assay<br/>Ubiquitination--drug effects<br/>Xenograft Model Antitumor Assays